// App-Quantinova.ai

137 : The Clinical and Laboratory Characteristics of Antiphospholipid Antibody Positive Patients Included in the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registryâ€)

Researchers

Presenter

  • Diane Zisa

Principal Investigators

  • Vittorio Pengo

  • Savino Sciascia

  • Maria Tektonidou

  • Amaia Ugarte

  • Maria Gerosa

  • H Michael Belmont

  • Rosario Lopez Pedrera

  • Lanlan Ji

  • Paul Fortin

  • Maria Efthymiou

  • Guilherme De Jesus

  • David Branch

  • Laura Andreoli

  • Michelle Petri

  • Ricard Cervera

  • Esther Rodriguez

  • Jason Knight

  • Tatsuya Atsumi

  • Rohan Willis

  • Maria Laura Bertolaccini

  • Hannah Cohen

  • Robert Roubey

  • Doruk Erkan

  • Medha Barbhaiya

Medical Centers

  • Hospital for Special Surgery, New York, NY.

  • Hospital for Special Surgery, Weill Cornell Medical College, New York, NY

  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil

  • Azienda Ospedaliera of Padova, University of Padova, Padova, Italy

  • Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piemonte and Valle d’Aosta Network for Rare Diseases, Department of Clinical and Biological Sciences, University of Turin, Torino, Italy

  • First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

  • Hospital Universitario Cruces, University of the Basque Country Autoimmune Diseases Research Unit, Department of Internal M edicine, BioCruces Health, Biscay, Spain

  • Istituto Ortopedico Gaetano Pini, University of Milan, Milan, Italy

  • NYU Langone Health, New York, NY

  • Maimonides Institute for Biomedical Research of Cordoba IMIBIC, Cordoba, Spain

  • Peking University, Beijing, China (People's Republic)

  • Division de Rhumatologie, Département de Médecine, CHU de QueÌbec – UniversiteÌ Laval, Axe maladies infectieuses et inflammatoires, Centre de recherche du CHU de QueÌbec – UniversiteÌ Laval, Canada, Quebec, QC, Canada

  • Kings College London, London, United Kingdom

  • IMS, Universidade Estadual do Rio de Janeiro, Rio De Janeiro, Brazil

  • University of Utah Health Sciences Center, Salt Lake City, UT

  • Rheumatology and Clinical Immunology, Spedali Civili and Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy, Brescia, Italy

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Department of Autoimmune Diseases, CELLEX-IDIBAPS, Hospital Clinic, Barcelona, Barcelona, Spain

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI

  • Antiphospholipid Standardization Laboratory, University of Texas Medical Branch, Galveston, TX

  • Kings College London, London, United Kingdom

  • University of North Carolina, Chapel Hill, NC

  • Hospital for Special Surgery, New York, NY.

  • APS ACTION, New York, NY

Locations

  • United States

  • Brazil

  • Italy

  • Greece

  • Spain

  • Canada

  • United Kingdom

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved